BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35740058)

  • 21. Analysis of follicular fluid and serum markers of oxidative stress in women with infertility related to endometriosis.
    Prieto L; Quesada JF; Cambero O; Pacheco A; Pellicer A; Codoceo R; Garcia-Velasco JA
    Fertil Steril; 2012 Jul; 98(1):126-30. PubMed ID: 22578534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study.
    Xu B; Geerts D; Hu S; Yue J; Li Z; Zhu G; Jin L
    Hum Reprod; 2020 Jun; 35(6):1306-1318. PubMed ID: 32478400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher SOD1 Gene Expression in Cumulus Cells From Infertile Women With Moderate and Severe Endometriosis.
    Donabela FC; Meola J; Padovan CC; de Paz CC; Navarro PA
    Reprod Sci; 2015 Nov; 22(11):1452-60. PubMed ID: 25947891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-532-3p: a possible altered miRNA in cumulus cells of infertile women with advanced endometriosis.
    da Silva LFI; Da Broi MG; da Luz CM; da Silva LECM; Ferriani RA; Meola J; Navarro PA
    Reprod Biomed Online; 2021 Mar; 42(3):579-588. PubMed ID: 33358886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression and role of oxidative stress markers in the serum and follicular fluid of patients with endometriosis.
    Liu F; He L; Liu Y; Shi Y; Du H
    Clin Exp Obstet Gynecol; 2013; 40(3):372-6. PubMed ID: 24283168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolomics analysis of follicular fluid in women with ovarian endometriosis undergoing in vitro fertilization.
    Karaer A; Tuncay G; Mumcu A; Dogan B
    Syst Biol Reprod Med; 2019 Feb; 65(1):39-47. PubMed ID: 29806498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
    Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I
    Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of controlled ovarian stimulation on thyroid stimulating hormone in infertile women.
    Du YJ; Xin X; Cui N; Jiang L; Yang AM; Hao GM; Gao BL
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():207-212. PubMed ID: 30731333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suboptimal response to GnRH-agonist trigger during oocyte cryopreservation: a case series.
    Russo M; Liu K; Chan C
    Reprod Biol Endocrinol; 2020 Jun; 18(1):59. PubMed ID: 32503566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insufficient Cumulus Expansion and Poor Oocyte Retrieval in Endometriosis-Related Infertile Women.
    Yin Y; Mao Y; Liu A; Shu L; Yuan C; Cui Y; Hou Z; Liu J
    Reprod Sci; 2021 May; 28(5):1412-1420. PubMed ID: 33409880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study on oxidative and antioxidative markers of serum and follicular fluid in GnRH agonist and antagonist cycles.
    Celik E; Celik O; Kumbak B; Yilmaz E; Turkcuoglu I; Simsek Y; Karaer A; Minareci Y; Ozerol E; Tanbek K
    J Assist Reprod Genet; 2012 Nov; 29(11):1175-83. PubMed ID: 22886458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ultra-long study: a randomized controlled trial evaluating long-term GnRH downregulation prior to ART in women with endometriosis.
    Tomassetti C; Beukeleirs T; Conforti A; Debrock S; Peeraer K; Meuleman C; D'Hooghe T
    Hum Reprod; 2021 Sep; 36(10):2676-2686. PubMed ID: 34370858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial.
    Dong J; Wang Y; Chai WR; Hong QQ; Wang NL; Sun LH; Long H; Wang L; Tian H; Lyu QF; Lu XF; Chen QJ; Kuang YP
    BJOG; 2017 Jun; 124(7):1048-1055. PubMed ID: 28276192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does the type of GnRH analogue used, affect live birth rates in women with endometriosis undergoing IVF/ICSI treatment, according to the rAFS stage?
    Drakopoulos P; Rosetti J; Pluchino N; Blockeel C; Santos-Ribeiro S; de Brucker M; Drakakis P; Camus M; Tournaye H; Polyzos NP
    Gynecol Endocrinol; 2018 Oct; 34(10):884-889. PubMed ID: 29648476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flexible ovarian stimulation in a poor responder: a case report and literature review.
    Xu B; Li Y
    Reprod Biomed Online; 2013 Apr; 26(4):378-83. PubMed ID: 23497915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin-releasing hormone agonist and antagonists, on follicular fluid stem cell factor and serum urocortin 1 levels on the day of oocyte retrieval.
    Celik O; Celik E; Yilmaz E; Celik N; Turkcuoglu I; Ulas M; Kumbak B; Aktan E; Ozerol I
    Arch Gynecol Obstet; 2013 Dec; 288(6):1417-22. PubMed ID: 23801011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis.
    Tamura H; Takasaki A; Nakamura Y; Numa F; Sugino N
    J Ovarian Res; 2014 Oct; 7():100. PubMed ID: 25331066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.
    Derksen L; Tournaye H; Stoop D; Van Vaerenbergh I; Bourgain C; Polyzos NP; Haentjens P; Blockeel C
    Reprod Biomed Online; 2014 Mar; 28(3):359-68. PubMed ID: 24456700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.